Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Postgraduate Medical Journal 2005;81:505-509; doi:10.1136/pgmj.2004.030304
Copyright © 2005 The Fellowship of Postgraduate Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardiner, D L
Right arrow Articles by Trenholme, K R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardiner, D L
Right arrow Articles by Trenholme, K R

REVIEW

Malaria in the post-genomics era: light at the end of the tunnel or just another train?

D L Gardiner 1, J S McCarthy 2, K R Trenholme 3

1 Malaria Biology Laboratory, Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research, Herston, Queensland, Australia
2 Clinical Tropical Medicine Laboratory, Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research
3 Malaria and Scabies Laboratory, Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research

Correspondence to:
Correspondence to:
Dr D Gardiner
Queensland Institute of Medical Research, 300 Herston Road, Herston 4006, Queensland, Australia; donG{at}qimr.edu.au

Malaria remains the third leading cause of death attributable to an infectious disease worldwide, with an estimated death toll of over 2 million per year, predominately in sub-Saharan Africa. The first serious attempt to eradicate this disease was unsuccessful, and 50 years later in 1998 a second programme coined "roll back malaria" was started. While this programme is at present unlikely to reach its stated aims, the completion of the genome sequencing projects on the human host, the mosquito vector, and the malaria parasite offers new hope. It is probable that the burden of disease caused by the most malignant form of the parasite Plasmodium falciparum can be, if not eliminated, then effectively suppressed within a generation through new and novel treatments aimed at all three arms of malaria control.


Keywords: malaria; vaccine; chemotherapy; vector control




This article has been cited by other articles:


Home page
Infect. Immun.Home page
A. A. Siddiqui, H. Bora, N. Singh, A. P. Dash, and Y. D. Sharma
Expression, Purification, and Characterization of the Immunological Response to a 40-Kilodalton Plasmodium vivax Tryptophan-Rich Antigen
Infect. Immun., June 1, 2008; 76(6): 2576 - 2586.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 The Fellowship of Postgraduate Medicine